Therapeutic efficacy during active phases of multiple sclerosis: Gait analysis and comparison with the EDSS score;Mesure de l'efficacité thérapeutique au cours d'une poussée de sclérose en plaques par l'analyse de la marche: Comparaison avec le score EDSS

Revue Neurologique

Volumn 157, Issue 6-7, 2001, Pages 649-654

  Fauchard Renard, ^a   Renard, J F ^a   Miret, N ^a   Hannequin, D ^a   Mihout, B ^a   Weber, J ^b  

^a Fédération des Sciences Neurologiques ^*  (France)

^b HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISABILITY; DRUG EFFICACY; FEMALE; FUNCTIONAL ASSESSMENT; GAIT; HUMAN; MALE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; PYRAMIDAL TRACT; STEROID THERAPY;

ADULT; FEMALE; GAIT; HUMANS; LOCOMOTION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 18144451029     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Clinical outcome measurements in multiple sclerosis trials
2. Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis
3. A randomized controlled trial of corticoosteroids in the treatment of acute optic neuritis
4. High dose intravenous nethylprednisolone in the treatment of multiple sclerosis
5. Gait characteristics in multiple sclerosis progressive charges and effects of exercice on parameters
6. Inter and intra rater scoring agreement using grades 1 to 3,5 of the Kurtzke expanded disability status scale (EDSS)
7. Upper extremity function in multiple sclerosis: Improving assessment sensitivity with box-and-block and nine-hole peg tests
8. Intensive immunosuppression in progressive multiple sclerosis: A randomized, three-arm study of high dose intravenous cyclophosphamide, plasma exchange, and ACTH
9. Phase-dependant modulations of anticipatory postural activity during human locomotion
10. Clinical gait assessment in the neurologically impaired reliability and meaningfulness
11. Gait assessment for neurologically impaired patients, standards for outcame assessment
12. Efficacy of Etodolac on gait in hip osteoarthritis as assessed by Bessou's locometer: A randomized crossover, double blind study versus placebo
13. A double blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: Clinical effects
14. Troubles de la marche. Éditions techniques
15. Interrater variability with the expanded disability status scale (EDSS) and functional systems (FS) in a multiple sclerosis clinical trial
16. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
17. Mesure des variables spatiotemporelles de la marche par le locomètre de Bessou en fonction de l'âge, de la taille, et du sexe chez 79 sujets sains
18. Récupération de la locomotion des patients hémiplégiques. Analyse par le locomètre
19. Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis
20. Neuroperformance evaluation of multiple sclerosis disease progression in a clinical trial: Implications for neurological outcomes
21. Kurtzke expanded disability status scale (EDSS). How best should it be used?
22. The natural history of multiple sclerosis: A geographically based study. 3. Multivariate analysis of predictive factors and models of outcome
23. Scales for rating impairment in multiple sclerosis: A critique